Clinical Trial Update: S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update describes S095029 as monotherapy and in combination with Sym021 in patients with advanced solid tumors, followed by an expans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• S095029
• Sym021

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING